Literature DB >> 30655280

Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients.

Samiksha Ghimire1, Bhagwan Maharjan2, Erwin M Jongedijk1, Jos G W Kosterink1, Gokarna R Ghimire3, Daan J Touw1, Tjip S van der Werf4,5, Bhabana Shrestha2, Jan-Willem C Alffenaar6.   

Abstract

Entities:  

Year:  2019        PMID： 30655280     DOI： 10.1183/13993003.02107-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.

Authors:  Marieke G G Sturkenboom; Anne-Grete Märtson; Elin M Svensson; Derek J Sloan; Kelly E Dooley; Simone H J van den Elsen; Paolo Denti; Charles A Peloquin; Rob E Aarnoutse; Jan-Willem C Alffenaar
Journal:  Clin Pharmacokinet       Date:  2021-03-06       Impact factor: 6.447

2.  Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates.

Authors:  Wei Zhou; Bing Yang; Yanyan Zou; Khaista Rahman; Xiaojian Cao; Yingying Lei; Ren Lai; Zhen F Fu; Xi Chen; Gang Cao
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

3.  Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.

Authors:  Samiksha Ghimire; Samriddhi Karki; Bhagwan Maharjan; Jos G W Kosterink; Daan J Touw; Tjip S van der Werf; Bhabana Shrestha; Jan-Willem Alffenaar
Journal:  BMJ Open Respir Res       Date:  2020-08

4.  A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.

Authors:  Jan-Willem C Alffenaar; Erwin M Jongedijk; Claudia A J van Winkel; Margaretha Sariko; Scott K Heysell; Stellah Mpagama; Daan J Touw
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.